基因表现分析市场规模、份额、成长分析（按产品、流程、数量、方法、应用和地区）- 产业预测，2025 年至 2032 年

2023 年全球基因表现分析市场规模价值 48 亿美元，预计将从 2024 年的 52 亿美元成长到 2032 年的 99.2 亿美元，预测期间（2025-2032 年）的复合年增长率为 8.4%。

受个人化医疗和精准治疗需求不断增长的推动，全球基因表现分析市场预计将显着增长。该市场使临床医生能够识别与特定疾病相关的独特基因特征，从而促进标靶治疗。次世代定序仪(NGS) 和微阵列技术的进步使得分析更加高效、更具成本效益，使研究人员能够管理大量资料并揭示关键的基因调控网络。癌症和心血管疾病等慢性疾病的发生率不断上升，推动了生物标记发现和治疗开发中对基因表现分析的需求。然而，需要解决诸如复杂的资料解释、熟练的生物资讯学专业人员短缺以及使用该技术的高成本挑战，以优化市场潜力并确保其在各个环境中的广泛应用。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

基因表现分析市场规模（按产品）

• 市场概况
• 试剂和耗材
  • 检测和套件
  • 酵素
  • DNA晶片
  • 其他的
• 装置
  • PCR
  • 次世代定序
  • DNA 微阵列
  • 其他的
• 服务

基因表现分析市场规模（依流程）

• 市场概况
• 样本采集
• 精製
• cDNA 合成与转化
• PCR 分析
• 资料分析与解释
• 其他的

基因表现分析市场规模（按容量）

• 市场概况
• 低至中等复杂度
• 高复合

基因表现分析市场规模（依方法）

• 市场概况
• RNA表达
• 启动子分析
• 蛋白质表现与转译后修饰分析

基因表现分析市场规模（按应用）

• 市场概况
• 药物研发
• 临床诊断
• 生物技术和微生物学
• 其他的

基因表现分析市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Illumina（USA）
• Thermo Fisher Scientific（USA）
• Bio-Rad Laboratories（USA）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Pacific Biosciences of California（USA）
• BGI（China）
• PerkinElmer Inc.（USA）
• Agilent Technologies（USA）
• Quest Diagnostics（USA）
• Promega Corporation（USA）
• Luminex Corporation（USA）
• Takara Bio（Japan）
• Danaher Corporation（USA）
• Merck Sharp & Dohme Corp.（USA）
• Genotypic Technology Pvt Ltd（India）
• Macrogen（South Korea）
• Eurofins Scientific（Luxembourg）
• SciGenom Labs Pvt. Ltd（India）
• Takara Holdings（Japan）

结论和建议

Global Gene Expression Analysis Market size was valued at USD 4.8 billion in 2023 and is poised to grow from USD 5.2 billion in 2024 to USD 9.92 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The global gene expression analysis market is poised for significant growth, fueled by the rising demand for personalized medicine and precision therapies. This market enables clinicians to identify unique gene signatures linked to specific diseases, thereby facilitating targeted treatments. Advances in next-generation sequencing (NGS) and microarray technologies have made analysis more efficient and cost-effective, allowing researchers to manage extensive datasets and uncover key gene regulatory networks. The increasing incidence of chronic diseases, such as cancer and cardiovascular disorders, heightens the need for gene expression analysis in biomarker discovery and therapeutic development. However, challenges like complex data interpretation, a shortage of skilled bioinformatics professionals, and the high costs of technology utilization must be addressed to optimize market potential and ensure broader adoption across settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Expression Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Expression Analysis Market Segmental Analysis

Global Gene Expression Analysis Market is segmented by Product, Process, Capacity, Technique, Application and region. Based on Product, the market is segmented into Reagents & Consumables, Instruments and Service. Based on Process, the market is segmented into Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation and Others. Based on Capacity, the market is segmented into Low- to Mid- Plex and High-Plex. Based on Technique, the market is segmented into RNA Expression, Promoter Analysis and Protein Expression & Posttranslational Modification Analysis. Based on Application, the market is segmented into Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Expression Analysis Market

The Global Gene Expression Analysis market is significantly propelled by the escalating incidence of chronic diseases such as cancer, cardiovascular issues, and neurological disorders. This trend underscores the necessity of gene expression analysis as it facilitates a deeper understanding of the molecular mechanisms associated with these conditions. Such insights are essential for enabling early diagnosis, enhancing treatment strategies, and advancing drug discovery efforts. Consequently, the growing need for innovative diagnostic and therapeutic solutions to combat these widespread health challenges is fostering a robust demand for gene expression analysis technologies in the market, ultimately driving its expansion and evolution.

Restraints in the Global Gene Expression Analysis Market

The Global Gene Expression Analysis market faces several restraints, primarily stemming from ethical and regulatory challenges. Concerns regarding the ethical use of genomic data, along with stringent regulations surrounding data privacy and protection, can hinder market growth. Adhering to data privacy laws, obtaining informed consent, and aligning research practices with ethical standards for managing patient information present significant obstacles for both researchers and companies in the gene expression analysis sector. As a result, the complexities associated with compliance may slow innovation and implementation within the market, ultimately impacting its overall development and expansion.

Market Trends of the Global Gene Expression Analysis Market

The Global Gene Expression Analysis market is increasingly dominated by the trend of single-cell gene expression analysis, driven by advancements in microfluidics, isolation methods, and sequencing technologies. This innovative approach empowers researchers to delve into cellular heterogeneity, identify rare cell populations, and observe dynamic gene expression changes at the individual cell level. This granular understanding is crucial for applications across developmental biology, cancer research, and precision medicine, enhancing drug discovery and therapeutic strategies. As the demand for more precise genetic insights continues to grow, the single-cell analysis segment is poised to significantly influence the market landscape in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Gene Expression Analysis Market Size by Product & CAGR (2025-2032)

• Market Overview
• Reagents & Consumables
  • Assays & kits
  • Enzymes
  • DNA chips
  • Others
• Instruments
  • PCR
  • NGS
  • DNA Microarrays
  • Others
• Service

Global Gene Expression Analysis Market Size by Process & CAGR (2025-2032)

• Market Overview
• Sample Collection
• Purification
• cDNA synthesis & conversion
• PCR Analysis
• Data analysis & interpretation
• Others

Global Gene Expression Analysis Market Size by Capacity & CAGR (2025-2032)

• Market Overview
• Low- to Mid- Plex
• High-Plex

Global Gene Expression Analysis Market Size by Technique & CAGR (2025-2032)

• Market Overview
• RNA Expression
• Promoter Analysis
• Protein Expression & Posttranslational Modification Analysis

Global Gene Expression Analysis Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery & Development
• Clinical Diagnostics
• Biotech & Microbiology
• Others

Global Gene Expression Analysis Market Size & CAGR (2025-2032)

• North America (Product, Process, Capacity, Technique, Application)
  • US
  • Canada
• Europe (Product, Process, Capacity, Technique, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Process, Capacity, Technique, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Process, Capacity, Technique, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Process, Capacity, Technique, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Sharp & Dohme Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genotypic Technology Pvt Ltd (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SciGenom Labs Pvt. Ltd (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Holdings (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations